HAPLN4
protein-codinghyaluronan and proteoglycan link protein 4, the group of V-set domain containing
Gene summary
Predicted to be a structural constituent of synapse-associated extracellular matrix. Predicted to be involved in GABAergic synaptic transmission; nervous system development; and skeletal system development. Predicted to be active in obsolete extracellular space; perineuronal net; and synapse. [provided by Alliance of Genome Resources, Jun 2026]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~8.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to HAPLN4 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_023002.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 2 | ||||
| missense | 66 | 66 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 66 | 0 | 2 | 68 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_075378.1 | 5 | MANE Select | |
| Ensembl | ENSP00000291481.5 | 5 | MANE Select | |
| Ensembl | ENSP00000568523.1 | 5 | Standard | |
| Ensembl | ENSP00000568523.1 | 5 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- skeletal system development
- cell adhesion
- central nervous system development
Molecular Function
- hyaluronic acid binding
Cellular Component
- extracellular matrix
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000291481
- Coding exons
- 5
- Length
- 7156
- Individuals with no LoFs
- 125577
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 36
- Defined
- 125613
- p
- 0.000143
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.73 | 192 | 273 | 0.704 | 0.0000203 | 2454 |
| Missense (PolyPhen) | 88 | 116.03 | 0.75842 | 1020 | ||
| Synonymous | 1.91 | 103 | 131 | 0.787 | 0.0000107 | 899 |
| Loss of Function | 2.31 | 6 | 15.9 | 0.376 | 9.46e-7 | 148 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000066 | 0.000062 | rare |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0.0015 | 0.0014 | notable |
| East Asian | 0.00051 | 0.00049 | rare |
| Finnish | 0.000057 | 0.000046 | rare |
| European (Non-Finnish) | 0.000033 | 0.000026 | rare |
| South Asian | 0.00016 | 0.00016 | rare |
| Other | 0.00036 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Binds to hyaluronic acid and may be involved in formation of the extracellular matrix. {ECO:0000250|UniProtKB:Q80WM4}.;
Recessive Scores
- pRec
- 0.114
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.235
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |